Dramatic Improvement of a Massive Plexiform Neurofibroma After Administration of Selumetinib - 09/03/20
Doi : 10.1016/j.pediatrneurol.2019.11.010
João Passos, MD a, b, Hipólito Nzwalo, MD, MSc, PhD c, ⁎ 
, Miguel Azevedo, MD d, Mário Tavares, MD e, Sofia Nunes, MD b
, Miguel Azevedo, MD d, Mário Tavares, MD e, Sofia Nunes, MD b a Neurology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
b Pediatric Neuro-Oncology Unit, Pediatrics Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
c Faculty of Medicine and Biomedical Sciences, Universidade do Algarve, Faro, Portugal
d Faculty of Medicine of the University of Lisbon, Lisbon, Portugal
e Radiology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
∗Communications should be addressed to: Nzwalo; Campus de Gambelas, 8005-139 Faro, Portugal.Campus de GambelasFaro8005-139Portugal
Keywords : Giant, Plexiform neurofibroma, Selumetinib, Treatment, Neoplasm
| Conflicts of interest: The authors declare that there are no conflicts of interest that may be inherent to the content of the publication. |
© 2019
Elsevier Inc. Tous droits réservés.
Vol 105
P. 69-70 - avril 2020 Retour au numéro
Article précédent
- An Unusual Case of New Tic Emergence and Exacerbation Following Treatment With Fluticasone Propionate
- Steven P. Trau
- A Rare Presentation of Congenital TORCH Infection
- Darrah N. Haffner, Shawn O’Connor, John Zempel
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?